Literature DB >> 1674771

Health inequalities among British civil servants: the Whitehall II study.

M G Marmot1, G D Smith, S Stansfeld, C Patel, F North, J Head, I White, E Brunner, A Feeney.   

Abstract

The Whitehall study of British civil servants begun in 1967, showed a steep inverse association between social class, as assessed by grade of employment, and mortality from a wide range of diseases. Between 1985 and 1988 we investigated the degree and causes of the social gradient in morbidity in a new cohort of 10,314 civil servants (6900 men, 3414 women) aged 35-55 (the Whitehall II study). Participants were asked to answer a self-administered questionnaire and attend a screening examination. In the 20 years separating the two studies there has been no diminution in social class difference in morbidity: we found an inverse association between employment grade and prevalence of angina, electrocardiogram evidence of ischaemia, and symptoms of chronic bronchitis. Self-perceived health status and symptoms were worse in subjects in lower status jobs. There were clear employment-grade differences in health-risk behaviours including smoking, diet, and exercise, in economic circumstances, in possible effects of early-life environment as reflected by height, in social circumstances at work (eg, monotonous work characterised by low control and low satisfaction), and in social supports. Healthy behaviours should be encouraged across the whole of society; more attention should be paid to the social environments, job design, and the consequences of income inequality.

Entities:  

Mesh:

Year:  1991        PMID: 1674771     DOI: 10.1016/0140-6736(91)93068-k

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  774 in total

1.  The role of socioeconomic status gradients in explaining differences in US adolescents' health.

Authors:  E Goodman
Journal:  Am J Public Health       Date:  1999-10       Impact factor: 9.308

2.  Coronary artery bypass surgery: are outcomes influenced by demographics or ability to pay?

Authors:  M C Mancini; E M Cush; K Sweatman; J Dansby
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

3.  Trends in perceived cost as a barrier to medical care, 1991-1996.

Authors:  D E Nelson; B L Thompson; S D Bland; R Rubinson
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

4.  Changes in social inequalities in health in the Basque Country.

Authors:  C Anitua; S Esnaola
Journal:  J Epidemiol Community Health       Date:  2000-06       Impact factor: 3.710

5.  "Broken windows" and the risk of gonorrhea.

Authors:  D Cohen; S Spear; R Scribner; P Kissinger; K Mason; J Wildgen
Journal:  Am J Public Health       Date:  2000-02       Impact factor: 9.308

6.  Organizational justice: evidence of a new psychosocial predictor of health.

Authors:  Marko Elovainio; Mika Kivimäki; Jussi Vahtera
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

7.  The McKeown thesis: a historical controversy and its enduring influence.

Authors:  James Colgrove
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

Review 8.  World Health Report 2000: how it removes equity from the agenda for public health monitoring and policy.

Authors:  P Braveman; B Starfield; H J Geiger
Journal:  BMJ       Date:  2001-09-22

9.  Joint effects of social class and community occupational structure on coronary mortality among black men and white men, upstate New York, 1988-92.

Authors:  D L Armstrong; D Strogatz; E Barnett; R Wang
Journal:  J Epidemiol Community Health       Date:  2003-05       Impact factor: 3.710

10.  Health problems and psychosocial work environment as predictors of long term sickness absence in employees who visited the occupational physician and/or general practitioner in relation to work: a prospective study.

Authors:  H Andrea; A J H M Beurskens; J F M Metsemakers; L G P M van Amelsvoort; P A van den Brandt; C P van Schayck
Journal:  Occup Environ Med       Date:  2003-04       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.